Status:
ACTIVE_NOT_RECRUITING
The Effect of Helminth Infection Plus COVID-19 Infection on the Immune Response and Intestinal Microorganisms
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
COVID-19
Eligibility:
All Genders
5+ years
Brief Summary
This is a pilot, cross-sectional, sample collection study to characterize the immune response and intestinal microorganisms in people with and without COVID-19 antibodies and helminth infection.
Detailed Description
This is a pilot, cross-sectional, sample collection study to characterize the immune response and intestinal microbiota in people with and without SARS-CoV-1 antibodies and helminth infection. A targ...
Eligibility Criteria
Inclusion
- Able to provide informed consent.
Exclusion
- Poor venous access precluding venipuncture.
- History of any illness or condition which, in the investigator's judgment, may substantially increase the risk associated with the participant's participation in the protocol, or compromise the scientific objectives.
- Participants may be co-enrolled in other studies; however study staff should be notified of co-enrollment.
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT04813328
Start Date
June 1 2021
End Date
April 1 2026
Last Update
December 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute for Research in Tuberculosis - International Centers for Excellence in Research (NIRT-ICER)
Chennai, Tamil Nadu, India